Psychedelics for Patients With Cancer: A Comprehensive ... - PubMed

Psychedelics show promise in reducing anxiety and depression in cancer patients, with significant reductions noted in several trials. Benefits may extend 6-12 months post-treatment, offering a new option beyond traditional antidepressants. However, studies are limited by small sizes and methodological issues, including increased blood pressure and heart rate.